Logo

ELISA

NephroSant Readies Launch of Kidney Transplant Rejection Assay
Premium

Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications.  

Biodesix Prices $72M IPO

Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share.

McGill Spinout Nplex Launching Highly Multiplexed ELISA System Next Year
Premium

The firm uses a miniaturized, bead-based-ELISA format to multiplex hundreds to thousands of immunoassays rapidly and without antibody cross-reactivity.

Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay
Premium

The San Francisco-based startup believes that its QiSant assay could help guide the use of immunosuppressive drugs and other therapies to prevent kidney transplant rejection.

Startup Nephrosant Aims to Launch Noninvasive Kidney Transplantation Test by Early 2020
Premium

The UCSF spinout aims to develop noninvasive tests to detect kidney injury for the transplantation field and to diagnose and monitor chronic disease.

Mar 22, 2019

Spontaneous Preterm Birth Clues Identified in Cervicovaginal Microbiome

Mar 11, 2019

Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent

Oct 9, 2018

10,000 Immunomes Project Establishes Initial Baseline for Healthy Immune System

Nov 9, 2017

Biovica Eyes 2020 Commercial Launch for DiviTum Metastatic Breast Cancer Assay
Premium

Apr 25, 2017

LabCorp Q1 Revenues Grow 5 Percent

Apr 11, 2017

MilliporeSigma Developing New Instrument for Single-Molecule Biomarker Detection
Premium

Jun 6, 2016

U of Ottawa Proteomics Study ID's Crohn's Disease, Ulcerative Colitis in IBD Patients
Premium

Oct 2, 2015

UCSF Team Using NHLBI Grant to ID Lung Disease Protein Markers in Premature Infants
Premium

Aug 7, 2015

New Study Describes Development of Simoa Assays for C. Diff Toxin Detection
Premium

Apr 3, 2015

PhasiQ Awarded NSF Grant to Develop Multiplex Protein Biomarker Test for DVT
Premium

Feb 20, 2015

Researchers Develop Simoa-based Assay for Dengue Fever Host Immune Response

Aug 21, 2014

Study Demonstrates Molecular Testing Superior to ELISA for Diagnosing Invasive Aspergillosis
Premium

Mar 20, 2013

Nuclea, Wilex Partner to Offer Breast Cancer Testing Service

Apr 18, 2012

Serametrix, Penn State Working to Personalize Immunotherapy for Pediatric Brain Cancer
Premium

Dec 7, 2011

OncoHealth Takes on HPV Testing Market with Protein-Based Assay

Sep 28, 2011

New VEGF Biomarker Data Illustrates Complexities of Personalizing Anti-Angiogenic Drugs
Premium

Jan 26, 2011

In FDA Appeal, Genentech Proposes Biomarker Strategy to Keep Avastin Available for Best Responders
Premium

Jan 14, 2011

FDA Official Offers Agency's Take on Protein IVDMIA Mock 510(k) Submissions
Premium

Jun 23, 2009

India's Super Religare Laboratories Launches Array-Based Food Intolerance Testing Service
Premium

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.